ALKS
Price
$28.12
Change
+$0.99 (+3.65%)
Updated
Sep 26, 12:57 PM (EDT)
Capitalization
4.48B
26 days until earnings call
PRGO
Price
$21.21
Change
+$0.46 (+2.22%)
Updated
Sep 26, 01:24 PM (EDT)
Capitalization
2.86B
40 days until earnings call
Interact to see
Advertisement

ALKS vs PRGO

Header iconALKS vs PRGO Comparison
Open Charts ALKS vs PRGOBanner chart's image
Alkermes
Price$28.12
Change+$0.99 (+3.65%)
Volume$612
Capitalization4.48B
Perrigo
Price$21.21
Change+$0.46 (+2.22%)
Volume$300
Capitalization2.86B
ALKS vs PRGO Comparison Chart in %
Loading...
ALKS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRGO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALKS vs. PRGO commentary
Sep 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALKS is a Buy and PRGO is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 26, 2025
Stock price -- (ALKS: $27.13 vs. PRGO: $20.76)
Brand notoriety: ALKS and PRGO are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: ALKS: 58% vs. PRGO: 150%
Market capitalization -- ALKS: $4.48B vs. PRGO: $2.86B
ALKS [@Pharmaceuticals: Generic] is valued at $4.48B. PRGO’s [@Pharmaceuticals: Generic] market capitalization is $2.86B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.86B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALKS’s FA Score shows that 1 FA rating(s) are green whilePRGO’s FA Score has 2 green FA rating(s).

  • ALKS’s FA Score: 1 green, 4 red.
  • PRGO’s FA Score: 2 green, 3 red.
According to our system of comparison, ALKS is a better buy in the long-term than PRGO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALKS’s TA Score shows that 4 TA indicator(s) are bullish while PRGO’s TA Score has 4 bullish TA indicator(s).

  • ALKS’s TA Score: 4 bullish, 5 bearish.
  • PRGO’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both ALKS and PRGO are a bad buy in the short-term.

Price Growth

ALKS (@Pharmaceuticals: Generic) experienced а -4.97% price change this week, while PRGO (@Pharmaceuticals: Generic) price change was -2.90% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +2.88%. For the same industry, the average monthly price growth was +23.85%, and the average quarterly price growth was +67.10%.

Reported Earning Dates

ALKS is expected to report earnings on Oct 22, 2025.

PRGO is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+2.88% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALKS($4.48B) has a higher market cap than PRGO($2.86B). PRGO has higher P/E ratio than ALKS: PRGO (2818.00) vs ALKS (13.11). ALKS YTD gains are higher at: -5.668 vs. PRGO (-16.528). PRGO has higher annual earnings (EBITDA): 612M vs. ALKS (450M). ALKS has more cash in the bank: 1.02B vs. PRGO (454M). ALKS has less debt than PRGO: ALKS (72.7M) vs PRGO (3.65B). PRGO has higher revenues than ALKS: PRGO (4.33B) vs ALKS (1.51B).
ALKSPRGOALKS / PRGO
Capitalization4.48B2.86B157%
EBITDA450M612M74%
Gain YTD-5.668-16.52834%
P/E Ratio13.112818.000%
Revenue1.51B4.33B35%
Total Cash1.02B454M224%
Total Debt72.7M3.65B2%
FUNDAMENTALS RATINGS
ALKS vs PRGO: Fundamental Ratings
ALKS
PRGO
OUTLOOK RATING
1..100
6051
VALUATION
overvalued / fair valued / undervalued
1..100
97
Overvalued
32
Undervalued
PROFIT vs RISK RATING
1..100
38100
SMR RATING
1..100
4092
PRICE GROWTH RATING
1..100
6285
P/E GROWTH RATING
1..100
332
SEASONALITY SCORE
1..100
n/a75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PRGO's Valuation (32) in the Pharmaceuticals Other industry is somewhat better than the same rating for ALKS (97) in the Biotechnology industry. This means that PRGO’s stock grew somewhat faster than ALKS’s over the last 12 months.

ALKS's Profit vs Risk Rating (38) in the Biotechnology industry is somewhat better than the same rating for PRGO (100) in the Pharmaceuticals Other industry. This means that ALKS’s stock grew somewhat faster than PRGO’s over the last 12 months.

ALKS's SMR Rating (40) in the Biotechnology industry is somewhat better than the same rating for PRGO (92) in the Pharmaceuticals Other industry. This means that ALKS’s stock grew somewhat faster than PRGO’s over the last 12 months.

ALKS's Price Growth Rating (62) in the Biotechnology industry is in the same range as PRGO (85) in the Pharmaceuticals Other industry. This means that ALKS’s stock grew similarly to PRGO’s over the last 12 months.

PRGO's P/E Growth Rating (2) in the Pharmaceuticals Other industry is in the same range as ALKS (33) in the Biotechnology industry. This means that PRGO’s stock grew similarly to ALKS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALKSPRGO
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
74%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
71%
Bullish Trend 1 day ago
55%
Momentum
ODDS (%)
Bearish Trend 1 day ago
67%
Bearish Trend 1 day ago
64%
MACD
ODDS (%)
Bearish Trend 1 day ago
73%
Bearish Trend 1 day ago
64%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
63%
Bearish Trend 1 day ago
66%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
62%
Bearish Trend 1 day ago
61%
Advances
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 3 days ago
61%
Declines
ODDS (%)
Bearish Trend 5 days ago
62%
Bearish Trend 5 days ago
65%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
68%
Aroon
ODDS (%)
Bullish Trend 1 day ago
76%
Bearish Trend 1 day ago
55%
View a ticker or compare two or three
Interact to see
Advertisement
ALKS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRGO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ABEMX17.17N/A
N/A
abrdn Emerging Markets Instl
TMSIX37.09N/A
N/A
Thrivent Mid Cap Stock S
GREAX11.19N/A
N/A
Goldman Sachs Real Estate Securities A
SAUMX31.38N/A
N/A
SA US Small Company
RNNEX69.63-0.69
-0.98%
American Funds New Economy R2E

ALKS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALKS has been loosely correlated with AMRX. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if ALKS jumps, then AMRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALKS
1D Price
Change %
ALKS100%
-2.45%
AMRX - ALKS
37%
Loosely correlated
-1.13%
COLL - ALKS
36%
Loosely correlated
-1.45%
DVAX - ALKS
33%
Loosely correlated
-2.31%
VTRS - ALKS
33%
Poorly correlated
-2.27%
PRGO - ALKS
31%
Poorly correlated
-2.95%
More

PRGO and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRGO has been loosely correlated with ORGO. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if PRGO jumps, then ORGO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRGO
1D Price
Change %
PRGO100%
-2.95%
ORGO - PRGO
47%
Loosely correlated
-4.49%
EOLS - PRGO
44%
Loosely correlated
-1.81%
AMRX - PRGO
38%
Loosely correlated
-1.13%
PBH - PRGO
33%
Loosely correlated
-0.84%
ZTS - PRGO
33%
Loosely correlated
-0.38%
More